Cristina Vilaplana

12PUBLICATIONS
46CO-AUTHORS
Gene and molecular therapyImmunogenetics (incl. genetic immunology)Major global burdens of diseaseMedical mycologyAnimal cell and molecular biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 29, 2026
CD4+ T cell markers associated with Treatment Outcomes in Tuberculosis: A Sub-analysis of a Phase IIB Trial of Acetylsalicylic acid and Ibuprofen as Adjunctive Therapy.

|Jul 01, 2026
Adjunctive ibuprofen in pre-extensively drug-resistant and extensively drug-resistant tuberculosis: a phase IIA open-label pilot clinical trial.

|Jan 29, 2026
Post-tuberculosis lung disease.

Yasmeen Al-Hindawi, Onno W Akkerman, Anthony Byrne

|Jun 27, 2023
SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen.

Lilibeth Arias, Kennedy Otwombe, Ziyaad Waja

|Feb 25, 2023
Surveillance of Daughter Micronodule Formation Is a Key Factor for Vaccine Evaluation Using Experimental Infection Models of Tuberculosis in Macaques.

Isabel Nogueira, Martí Català, Andrew D White

|Jan 21, 2023
Mouse Models for Mycobacterium tuberculosis Pathogenesis: Show and Do Not Tell.

Pablo Soldevilla, Cristina Vilaplana, Pere-Joan Cardona

Pageof 2

Frequent Collaborators

3 joint publications

Pere-Joan Cardona

3 joint publications

Judith Farrés

2 joint publications

Chiara Sopegno

2 joint publications

Clara Prats